Schroder Investment Management Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Buy |
37,481
+13,339
| +55% | +$1.39M | ﹤0.01% | 816 |
|
|
2025
Q1 | $2.86M | Hold |
24,142
| – | – | ﹤0.01% | 856 |
|
|
2024
Q4 | $2.05M | Sell |
24,142
-34,158
| -59% | -$2.9M | ﹤0.01% | 916 |
|
|
2024
Q3 | $5.23M | Hold |
58,300
| – | – | 0.01% | 778 |
|
|
2024
Q2 | $4.69M | Hold |
58,300
| – | – | 0.01% | 797 |
|
|
2024
Q1 | $4.65M | Hold |
58,300
| – | – | 0.01% | 795 |
|
|
2023
Q4 | $4.64M | Buy |
+58,300
| New | +$4.64M | 0.01% | 780 |
|
|
2019
Q3 | – | Sell |
-2,948
| Closed | -$76K | – | 1279 |
|
|
2019
Q2 | $76K | Buy |
+2,948
| New | +$76K | ﹤0.01% | 1142 |
|